celecoxib has been researched along with oxidopamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ardestani, MS; Moghaddamt, HF; Navidpour, L; Rahmim, A; Saffari, M; Shafiee, A | 1 |
| Bortolanza, M; Crivelaro do Nascimento, G; Del Bel, EA; Ferrari, DP; Ferreira-Junior, NC; Guimaraes, FS | 1 |
| Buechner, S; Dassati, S; Schweigreiter, R; Waldner, A | 1 |
3 other study(ies) available for celecoxib and oxidopamine
| Article | Year |
|---|---|
Dopaminergic but not glutamatergic neurotransmission is increased in the striatum after selective cyclooxygenase-2 inhibition in normal and hemiparkinsonian rats.
Topics: Animals; Celecoxib; Corpus Striatum; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Glutamic Acid; Male; Microdialysis; Oxidopamine; Parkinsonian Disorders; Pyrazoles; Rats; Rats, Wistar; Substantia Nigra; Sulfonamides; Synaptic Transmission | 2008 |
Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease.
Topics: Amidohydrolases; Analgesics; Animals; Benzamides; Brain; Cannabidiol; Capsaicin; Carbamates; Celecoxib; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Morphine; Nociception; Oxidopamine; Pain; Parkinson Disease; Piperidines; Pyrazoles; Thienamycins | 2020 |
Celecoxib promotes survival and upregulates the expression of neuroprotective marker genes in two different in vitro models of Parkinson's disease.
Topics: Apolipoproteins D; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Celecoxib; Cell Line, Tumor; Hippocampus; Humans; Neuroprotection; Oxidopamine; Paraquat; Parkinson Disease, Secondary; Up-Regulation | 2021 |